Research output per year
Research output per year
Personal profile
Headline
PROFESSOR Medicine, Cardiology
Fingerprint
Dive into the research topics where Juan Badimon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: The EMPATROPISM-FE trial
Angermann, C. E., Sehner, S., Gerhardt, L. M. S., Santos-Gallego, C. G., Requena-Ibanez, J. A., Zeller, T., Maack, C., Sanz, J., Frantz, S., Ertl, G. & Badimon, J. J., 21 Apr 2025, In: European Heart Journal. 46, 16, p. 1507-1523 17 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes
Pérez, M. S., Rodríguez-Capitán, J., Requena-Ibáñez, J. A., Santos-Gallego, C. G., Urooj Zafar, M., Escolar, G., Mancini, D., Mitter, S., Lam, D., Contreras, J. P., Fergus, I., Atallah-Lajam, F., Abascal, V., Lala, A., Moreno, P., Moss, N., Lerakis, S., Sanz, J., Fuster, V. & Badimon, J. J., Feb 2025, In: Cardiovascular Drugs and Therapy. 39, 1, p. 155-164 10 p.Research output: Contribution to journal › Review article › peer-review
11 Scopus citations -
Sotagliflozin: Two Birds with One Stone?
Requena-Ibáñez, J. A., Kindberg, K. M., Santos-Gallego, C. G., Zafar, M. U. & Badimon, J. J., 2025, (Accepted/In press) In: Cardiovascular Drugs and Therapy.Research output: Contribution to journal › Review article › peer-review
-
Are Sodium-Glucose Cotransporter-2 Inhibitors the Cherry on Top of Cardio-Oncology Care?
Gongora, C. A., Zhang, L., Mattei, J. L., Ruiz-Mori, E., Gonzalez-Robledo, G., Slipczuk, L., Lara, J., Cossio-Aranda, J. E. & Badimon, J., 2024, (Accepted/In press) In: Cardiovascular Drugs and Therapy.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Does One Size Fits All?
Roldan, V. & Badimon, J. J., Dec 2024, In: Cardiovascular Drugs and Therapy. 38, 6, p. 1099-1101 3 p.Research output: Contribution to journal › Editorial
Press/Media
-
Study Findings from Icahn School of Medicine at Mount Sinai Provide New Insights into Cancer (Are Sodium-glucose Cotransporter-2 Inhibitors the Cherry On Top of Cardio-oncology Care?)
Badimon, J. & Gongora, C.
29/07/24
1 item of Media coverage
Press/Media
-
EMPA-TROPISM: Empagliflozin improves LV remodeling in patients with heart failure
20/01/21
1 item of Media coverage
Press/Media
-
Empagliflozin Also Beneficial in Heart-Failure Patients Without Diabetes
25/11/20
1 item of Media coverage
Press/Media
-
Empagliflozin LV remodeling not reliant on glucose lowering
25/11/20
1 item of Media coverage
Press/Media